Nifty Pharma index has moved in tandem with the headline index, with nearly 5% returns in the last month, with stocks gaining by up to 22% in this period. Decoding the charts, Nilesh Jain, Head Vice President, Equity Research, Technical and Derivatives at Centrum Broking, said that the CNX PHARMA index has formed an inverse head & shoulder pattern where the neckline is placed near 22,028 levels. A break above 22,200 will add further bullishness for the 22,500-22,800 level, while support is near 21550. Here are 5 stocks to buy from various brokerages:
Nuvoco Vistas plans to raise 1,200 crore through CCDs and CCPS in Vadraj Cement to refinance bridge facilities used for the 1,800 crore acquisition. Trust Capital is arranging the fundraising, which involves merging Vanya into Vadraj after the acquisition. The funds will refinance short-term debt through long-term maturity instruments.
White House confirms President Trump accepted Elon Musk's apology. This follows Musk's regret expressed on X regarding his posts about Trump. Earlier, Vice President Vance and Chief of Staff Wiles spoke with Musk. Republican lawmakers urged Musk to reconcile with Trump. They also sought his support for Trump's domestic policy bill. Allies tried to de-escalate the feud through outreach.
President Trump indicated a willingness to extend the July 8 deadline for trade talks, contingent on countries negotiating in good faith. Treasury Secretary Scott Bessent echoed this sentiment, suggesting flexibility for ongoing negotiations with nations like South Korea, Japan, and the EU. Trump also mentioned plans to send out final deal offers, signaling a take-it-or-leave-it approach for some countries.
The Cayman Islands are emerging as a preferred destination for Indian software startups chasing global markets, offering greater flexibility in raising capital, whether from India or abroad. The self-governing British Overseas Territory is a region of interest for software-as-a-service (SaaS) companies scaling up their international ambitions.
Jubilant Bhartia Group's promoters are selling minority stakes in listed companies to raise 2,000 crore for partially funding the acquisition of a 40% stake in Hindustan Coca-Cola Beverages (HCCB). Goldman Sachs Asset Management has already raised $600 million for the deal, and the group is divesting non-core assets. The deal values Coca-Colas bottling arm at 31,250 crore.
Analysts predict significant growth for select stocks. Bansal Wire Industries is projected to surge 22% due to its expanding steel wire plant. Tata Communications anticipates a 16.6% rise driven by data revenue and strategic asset monetization. Home First Finance expects an 18.4% increase, positioned favorably in the affordable housing finance sector.
